Pharmacokinetic Study in Patients With Unresectable Hepatocellular Carcinoma (HCC) Receiving Treatment With LifePearl Microspheres Loaded With Doxorubicin

Trial Profile

Pharmacokinetic Study in Patients With Unresectable Hepatocellular Carcinoma (HCC) Receiving Treatment With LifePearl Microspheres Loaded With Doxorubicin

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 29 Nov 2017

At a glance

  • Drugs Doxorubicin (Primary)
  • Indications Liver cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Terumo
  • Most Recent Events

    • 23 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.
    • 25 Apr 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
    • 25 Apr 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top